Junan Li
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
Papers in
-
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 8
- Ubiquitin and proteasome pathways 7
- Oncology 41
- Cancer-related Molecular Pathways 27
- Co-authors
- Ming‐Daw Tsai (19 shared papers)Anjali Mahajan (6 shared papers)Ming Poi (24 shared papers)In‐Ja L. Byeon (6 shared papers)Christopher M. Weghorst (17 shared papers)Thomas L. Selby (5 shared papers)Thomas J. Knobloch (11 shared papers)Karen L. Ericson (2 shared papers)
- Journals
- Biochemistry (12 papers)Molecular Carcinogenesis (7 papers)Anticancer Research (5 papers)American Journal of Pharmaceutical Education (5 papers)Journal of the American Pharmacists Association (3 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Junan Li
96 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 139
- Oncology 660
- Cancer Research 318
- Molecular Biology 1.2k
- Otorhinolaryngology 59
- Cell Biology 209
Countries citing papers authored by Junan Li
This map shows the geographic impact of Junan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junan Li more than expected).
Fields of papers citing papers by Junan Li
This network shows the impact of papers produced by Junan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junan Li. The network helps show where Junan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 471 | |
| 2 | 2011 | 247 | |
| 3 | 1998 | 135 | |
| 4 | 2021 | 88 | |
| 5 | 2002 | 81 | |
| 6 | 2015 | 60 | |
| 7 | 2019 | 50 | |
| 8 | 2008 | 50 | |
| 9 | 2001 | 42 | |
| 10 | 2004 | 41 | |
| 11 | 1999 | 41 | |
| 12 | 2019 | 35 | |
| 13 | 2020 | 34 | |
| 14 | 1999 | 34 | |
| 15 | 2017 | 28 | |
| 16 | 2003 | 28 | |
| 17 | Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer. | 2011 | 28 |
| 18 | 2019 | 27 | |
| 19 | 2003 | 27 | |
| 20 | 2004 | 25 |
About Junan Li
Junan Li is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Epidemiology and Hematology, having authored 103 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (27 papers), RNA modifications and cancer (9 papers), Microtubule and mitosis dynamics (8 papers), Multiple Myeloma Research and Treatments (8 papers), Epigenetics and DNA Methylation (8 papers), Innovations in Medical Education (7 papers), Ubiquitin and proteasome pathways (7 papers) and Research on Leishmaniasis Studies (6 papers). The work is most often cited by research in Oncology (660 citations), Cancer Research (318 citations), Molecular Biology (1.2k citations), Otorhinolaryngology (59 citations) and Cell Biology (209 citations). Junan Li has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Ming‐Daw Tsai, Anjali Mahajan, Ming Poi, In‐Ja L. Byeon, Christopher M. Weghorst, Thomas L. Selby, Thomas J. Knobloch, Karen L. Ericson, Paul E. O’Maille and Chunhua Yuan. Their work appears in journals such as Biochemistry, Molecular Carcinogenesis, Anticancer Research, American Journal of Pharmaceutical Education and Journal of the American Pharmacists Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.